Ornella Valenti - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Forro T, Valenti O, Lasztoczi B, Klausberger T. Temporal organization of GABAergic interneurons in the intermediate CA1 hippocampus during network oscillations. Cerebral Cortex (New York, N.Y. : 1991). 25: 1228-40. PMID 24275828 DOI: 10.1093/Cercor/Bht316  1
2012 Lapray D, Lasztoczi B, Lagler M, Viney TJ, Katona L, Valenti O, Hartwich K, Borhegyi Z, Somogyi P, Klausberger T. Behavior-dependent specialization of identified hippocampal interneurons. Nature Neuroscience. 15: 1265-71. PMID 22864613 DOI: 10.1038/Nn.3176  1
2012 Valenti O, Gill KM, Grace AA. Different stressors produce excitation or inhibition of mesolimbic dopamine neuron activity: response alteration by stress pre-exposure. The European Journal of Neuroscience. 35: 1312-21. PMID 22512259 DOI: 10.1111/j.1460-9568.2012.08038.x  1
2011 Valenti O, Cifelli P, Gill KM, Grace AA. Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 12330-8. PMID 21865475 DOI: 10.1523/JNEUROSCI.2808-11.2011  1
2011 Valenti O, Lodge DJ, Grace AA. Aversive stimuli alter ventral tegmental area dopamine neuron activity via a common action in the ventral hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 4280-9. PMID 21411669 DOI: 10.1523/JNEUROSCI.5310-10.2011  1
2010 Valenti O, Grace AA. Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 845-60. PMID 19751544 DOI: 10.1017/S1461145709990599  1
2009 Valenti O, Grace AA. Entorhinal cortex inhibits medial prefrontal cortex and modulates the activity states of electrophysiologically characterized pyramidal neurons in vivo. Cerebral Cortex (New York, N.Y. : 1991). 19: 658-74. PMID 18632738 DOI: 10.1093/cercor/bhn114  1
2007 Sibille P, Lopez S, Brabet I, Valenti O, Oueslati N, Gaven F, Goudet C, Bertrand HO, Neyton J, Marino MJ, Amalric M, Pin JP, Acher FC. Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists. Journal of Medicinal Chemistry. 50: 3585-95. PMID 17602546 DOI: 10.1021/jm070262c  1
2005 Valenti O, Mannaioni G, Seabrook GR, Conn PJ, Marino MJ. Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons. The Journal of Pharmacology and Experimental Therapeutics. 313: 1296-304. PMID 15761115 DOI: 10.1124/jpet.104.080481  1
2003 Valenti O, Marino MJ, Conn PJ. Modulation of excitatory transmission onto midbrain dopaminergic neurons of the rat by activation of group III metabotropic glutamate receptors. Annals of the New York Academy of Sciences. 1003: 479-80. PMID 14684494 DOI: 10.1196/annals.1300.058  1
2003 Marino MJ, Valenti O, O'Brien JA, Williams DL, Conn PJ. Modulation of inhibitory transmission in the rat globus pallidus by activation of mGluR4. Annals of the New York Academy of Sciences. 1003: 435-7. PMID 14684481 DOI: 10.1196/annals.1300.045  1
2003 Marino MJ, Williams DL, O'Brien JA, Valenti O, McDonald TP, Clements MK, Wang R, DiLella AG, Hess JF, Kinney GG, Conn PJ. Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment. Proceedings of the National Academy of Sciences of the United States of America. 100: 13668-73. PMID 14593202 DOI: 10.1073/pnas.1835724100  1
2003 Valenti O, Marino MJ, Wittmann M, Lis E, DiLella AG, Kinney GG, Conn PJ. Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 7218-26. PMID 12904482 DOI: 10.1523/Jneurosci.23-18-07218.2003  1
2003 Marino MJ, Valenti O, Conn PJ. Glutamate receptors and Parkinson's disease: opportunities for intervention. Drugs & Aging. 20: 377-97. PMID 12696997 DOI: 10.2165/00002512-200320050-00006  1
2002 Besong G, Battaglia G, D'Onofrio M, Di Marco R, Ngomba RT, Storto M, Castiglione M, Mangano K, Busceti CL, Nicoletti FR, Bacon K, Tusche M, Valenti O, Conn PJ, Bruno V, et al. Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 5403-11. PMID 12097492 DOI: 10.1523/Jneurosci.22-13-05403.2002  1
2002 Valenti O, Conn PJ, Marino MJ. Distinct physiological roles of the Gq-coupled metabotropic glutamate receptors Co-expressed in the same neuronal populations. Journal of Cellular Physiology. 191: 125-37. PMID 12064455 DOI: 10.1002/jcp.10081  1
2001 Mannaioni G, Marino MJ, Valenti O, Traynelis SF, Conn PJ. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 5925-34. PMID 11487615 DOI: 10.1523/Jneurosci.21-16-05925.2001  1
Show low-probability matches.